Get The Alerts + Report

UNITED THERAPEUTICS Corp [UTHR]

Reporting date: 10/06/2025

⚠️ Neutral Insider Mix Detected

📝 What Happened

  • Insider: BENKOWITZ MICHAEL
  • Role: PRESIDENT AND COO
  • Company: UNITED THERAPEUTICS Corp (UTHR)
  • Transaction Date(s): 2025-10-06
  • Table I (Non-Derivative Securities)
    • Sale : 22,500.00
    • Average Sale Price: 450.24
    • Total Value: 22,500.00 * 450.24 = ~$10,130,438.91
    • Post-Transaction Direct Holdings: 2,648.00
    • Indirect Holdings: 0.00
    • 10b5-1 Plan Used? Yes

    📄 Summary

    BENKOWITZ MICHAEL, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), executed a mixed transaction involving 22,500 shares on October 06, 2025, at an average price of $450.24, realizing proceeds of about ~$10,130,439. After the transaction, he now holds 2,648 direct shares; 0 indirect shares. For retail traders, this is a neutral event: planned option exercise with subsequent 10b5-1 sales, routine liquidity rather than a clear negative signal.

    🔑 Interpretation

    • Type: Comp-related (exercise of options and sales executed under a Rule 10b5-1 trading plan)
    • Disposition: Shares were sold immediately (multiple S transactions executed the same trade date following option exercises)
    • Size Context: The sales (22,500 shares; ~ $10.1M proceeds) are sizable in absolute dollars but were offset by same-day acquisitions via option exercises — consistent with planned liquidity rather than ad hoc insider selling.
    • ATH Metric: I cannot fetch current all-time high/low price data from the web in this environment, so I cannot determine whether the trade occurred near an all-time high or low. Please verify latest ATH/ATL data separately to assess opportunistic timing versus routine execution.
    • Outlier Check: Not clearly an outlier based on this single filing — the pattern (exercise + sell via 10b5-1) is common for insiders monetizing options; historical comparison would require prior filings for confirmation.

    📊 Bullish or Bearish?

    Decide: Neutral

    Neutral. The filing shows concurrent option exercises (M) and sales (S) executed under a 10b5-1 plan, producing roughly equal acquired and disposed share quantities; this looks like planned liquidity rather than an opportunistic negative signal. Data in this filing is complete for the reported transactions but does not show cluster activity.

    ✅ Bottom Line (Retail Takeaway)

    This transaction looks like routine profit-taking rather than a bearish signal. For retail traders, it’s noise, not a tradeable event — not worth short-/mid-term action unless corroborated by material sales from multiple senior executives or a broader pattern of insider exits.